Molecular and Cellular Biology · 1998 · 164 citations · 65 references
Life SciencesCell BiologyImmunologyApoptosisGene ExpressionTranscriptional RegulationApoptosis RegulationApoptotic Signal TransductionApoptotic SignalingDeath ReceptorsProgrammed Cell DeathPromoter RegulationApoptotic Signaling PathwaysDeath Ligand SignalingFas Ligand-mediated ApoptosisFas Receptor SignalingProgrammed Cell Death RegulationTranscriptional Regulation Of ApoptosisTransient ExpressionTransient Gene Expression
Activation-induced transcriptional upregulation of the ligand for Fas (FasL) and the resulting apoptosis of Fas-bearing cells constitute essential steps in a host of normal and pathological processes. Here we describe an activation-inducible cis-acting regulatory element in the fasL promoter that is required for gene expression. Oligonucleotide competition and antibody supershift analyses identified two activation-induced DNA-binding species: Egr-1 (NGFI-A, krox-24, zif268, TIS-8), a transcription factor that has been implicated in growth, differentiation, and apoptosis; and Egr-3 (PILOT), a transcription factor of no previously known function. Activation-induced expression of Egr-3, like that of FasL, was inhibited by cyclosporin A, whereas expression of Egr-1 was unaffected. Transient expression of Egr-3 alone increased fasL promoter activity in a cyclosporin A-insensitive manner, whereas expression of Egr-1 had little effect. Moreover, endogenous fasL mRNA was induced in nonlymphoid cells by forced expression of Egr-3 in the absence of any other stimulus. These studies identify a critical Egr family-binding site in the fasL promoter and demonstrate that activation-induced Egr-3, but not Egr-1, directly upregulates fasL transcription in response to activating stimuli.
65
George M. Church, W Gilbert · Proceedings of the National Academy of Sciences · 1984 · 8.2K citations · Full text
Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Thomas S. Griffith, Thomas Brunner, Sharon M. Fletcher et al. · Science · 1995 · 2K citations
Medicine, Immunology, Ophthalmology +17
Generalized lymphoproliferative disease in mice, caused by a point mutation in the fas ligand
Tomohiro Takahashi, Masato Tanaka, Camllynn I. Brannan et al. · Cell · 1994 · 1.5K citations
Life Sciences, Immunology, Pathology +12